A Nationwide 2010–2012 Analysis of U.S. Health Care Utilization in Inflammatory Bowel Diseases

This publication has 21 references indexed in Scilit:

• The Era of Delivery System Reform Begins
  JAMA, 2013
• Changing Crohn's disease management: Need for new goals and indices to prevent disability and improve quality of life
  Journal of Crohn's and Colitis, 2012
• Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States
  Inflammatory Bowel Diseases, 2011
• Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease
  Inflammatory Bowel Diseases, 2011
• AGA Medical Position Statement on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
  Gastroenterology, 2010
• AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
  Gastroenterology, 2010
• Variation in Care in Pediatric Crohn Disease
  Journal of Pediatric Gastroenterology and Nutrition, 2009
• American Gastroenterological Association Institute Medical Position Statement on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
  Gastroenterology, 2006
• American gastroenterological association medical position statement: perianal Crohn’s disease1 1Address requests for reprints to: Chair, Clinical Practice Committee, AGA National Office, c/o Membership Department, 4930 Del Ray Avenue, Bethesda, Maryland 20814. Fax: (301) 654-5920.This Medical Position Statement has been developed under the aegis of the c (AGA). It provides preferred approaches to specific medical problems or issues. The statements herein are derived from the data available at the time of their creation and may need to be modified as new information is generated. Unless otherwise stated, these statements are intended for adult patients. The strength of the evidence upon which the statements are based is noted, with prospective, randomized, controlled trials being the strongest. When adequate data are absent, expert consensus may be used and will be identified as such. This document is not to be construed as a standard of care. All decisions regarding the care of a patient should be made by the physician in consideration of all aspects of the patient’s specific medical circumstances.
  Gastroenterology, 2003
• American Gastroenterological Association medical position statement: Guidelines on osteoporosis in gastrointestinal diseases, This document presents the official recommendations of the American Gastroenterological Association (AGA) Committee on Osteoporosis in Gastrointestinal Disease. It was approved by the Clinical Practice Committee on September 21, 2002, and by the AGA Governing Board on November 1, 2002.
  Gastroenterology, 2003